Diagnostic/Device Pipeline

Zomedica has entered into a research collaboration agreement with Celsee Diagnostics, Inc., an innovator of human health products in the emerging field of liquid biopsy. The research project defined in the agreement aims to test the feasibility of Celsee’s liquid biopsy technology for veterinary application as a canine cancer diagnostic.

Therapeutic Pipeline

Zomedica is developing a drug pipeline of FDA Center for Veterinary Medicine (FDA-CVM) approved drugs that address the urgent and pervasive needs of clinical veterinarians. Disclosed products are identified below with other undisclosed therapeutics at various early-stages of development.